Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 26Breast Neoplasms 5Leiomyoma 3Neoplasms 2Sleep Wake Disorders 1Sarcopenia 1Prostatectomy 1Polycystic Ovary Syndrome 1Pelvic Pain 1Osteoporosis 1Neoplasm Metastasis 1Kallmann Syndrome 1Hypogonadism 1Hyperprolactinemia 1Highly Endocrine Responsive Operable Breast Cancer 1Hemorrhage 1Fatigue 1Endometriosis 1Cardiovascular Diseases 1Breast Neoplasms, Male 1Advanced Prostate Cancer 1Adenomyosis 1

Interventions

Tranexamic Acid 6Sodium Chloride 2Ringer's Lactate 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Uterine Artery Embolization 1Tourniquets 1Sutures 1Surgicel 1Saline Solution 1Rivaroxaban 1Ringer's Solution 1Pancreaticoduodenectomy 1Mannitol 1Lenalidomide 1Ibuprofen 1Goserelin 1Gonadotropin-Releasing Hormone 1Furosemide 1FloSeal Matrix 1Esomeprazole 1Data Collection 1Dalteparin 1Crystalloid Solutions 1Colloids 1Blood Transfusion 1Bevacizumab 1Aspirin 1Arginine Vasopressin 1Arginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemorrhage × Gonadotropin-Releasing Hormone × Clear all
NCT01581944 2012-04-20

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

Mt. Hope Maternity Hospital

Phase 3 Completed
68 enrolled

Hemorrhage, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡